Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
609
datasets available to search
ShareScore release 0.9.0
Dataset results
609 results for “Event study”
Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax in Combination With Intravenous (IV) Obinutuzumab or Oral Ibrutinib in Adult Participants With Untreated Chronic Lympho
ClinicalTrials.gov study NCT05105841. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Pa
ClinicalTrials.gov study NCT07155174. IPD Sharing: YES. Countries: 4. Publications: 0.
Study to Evaluate Adverse Events, Optimal Dose, and Change in Disease Activity, With Livmoniplimab in Combination With Budigalimab Plus Chemotherapy Versus IV Infused Pembrolizumab Plus Chemotherapy i
ClinicalTrials.gov study NCT06236438. IPD Sharing: YES. Countries: 12. Publications: 0.
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
ClinicalTrials.gov study NCT07276997. IPD Sharing: YES. Countries: 1. Publications: 0.
Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial (TRIDENT) Cognitive Sub-Study
ClinicalTrials.gov study NCT03785067. IPD Sharing: Not stated. Countries: 2. Publications: 0.
A Study of HRS-5346 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular Events
ClinicalTrials.gov study NCT06816264. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Study to Evaluate Adverse Events and Change in Disease Activity in Adult Participants With B-Cell Malignancies Receiving Oral ABBV-525 Tablets
ClinicalTrials.gov study NCT05618028. IPD Sharing: NO. Countries: 10. Publications: 0.
Study of Intravenous (IV) ABBV-637 Alone or in Combination With IV Docetaxel/Osimertinib to Assess Adverse Events and Change in Disease Activity in Adult Participants With Relapsed/Refractory (R/R) So
ClinicalTrials.gov study NCT04721015. IPD Sharing: NO. Countries: 8. Publications: 0.
A EUROpean Randomized Study on Blood-thinners and Cholesterol-lowering Treatments to Prevent Future Vascular Events in People With Covert Brain Infarcts (CBI)
ClinicalTrials.gov study NCT07012629. IPD Sharing: YES. Countries: 5. Publications: 0.
Prediction Of Serious Adverse Event in Emergency Department With dysKAlemia, Retrospective Study
ClinicalTrials.gov study NCT05788523. IPD Sharing: NO. Countries: 1. Publications: 0.
Study to Evaluate Adverse Events and Change in Disease Activity When Intravenously (IV) Infused Livmoniplimab is Used in Combination With IV Infused Budigalimab in Adult Participants With Urothelial C
ClinicalTrials.gov study NCT06632951. IPD Sharing: YES. Countries: 8. Publications: 0.
Study to Evaluate Adverse Events, Change in Disease Activity, Movement of Oral ABBV-623 and ABBV-992 Tablets in the Body of Adult Participants With B-cell Cancers
ClinicalTrials.gov study NCT04804254. IPD Sharing: NO. Countries: 3. Publications: 0.
The Multi-center Study of Comprehensive Atrial Fibrillation Regurgitation and Recurrent Events Evaluation
ClinicalTrials.gov study NCT07085650. IPD Sharing: NO. Countries: 1. Publications: 0.
Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Lemzoparlimab With or Without Oral/IV Dexamethasone and in Combination With Oral/IV/Subcutaneous Anti-Myeloma Regimens
ClinicalTrials.gov study NCT04895410. IPD Sharing: NO. Countries: 7. Publications: 0.
Study to Assess Adverse Events and Change in Disease Activity in Previously Treated Adult Participants Receiving Intravenous (IV) ABBV-400 With Unresectable Metastatic Colorectal Cancer in Combination
ClinicalTrials.gov study NCT06107413. IPD Sharing: YES. Countries: 8. Publications: 0.
A Study to Assess the Adverse Events and How Subcutaneous (SC) Injections and Intravenous (IV) Infusions of ABBV-142 Move Through the Body of Healthy Adult Participants
ClinicalTrials.gov study NCT06774313. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung
ClinicalTrials.gov study NCT04928846. IPD Sharing: YES. Countries: 32. Publications: 0.
A Study to Assess Adverse Events, and How Intravenously (IV) Infused ABBV-969 Moves Through the Bodies of Adult Participants With Metastatic Castration-Resistant Prostate Cancer
ClinicalTrials.gov study NCT06318273. IPD Sharing: NO. Countries: 7. Publications: 0.
Study to Evaluate Adverse Events, Change in Disease Activity, and How Oral ABBV-101 Moves Through the Body in Adult Participants With B-Cell Malignancies
ClinicalTrials.gov study NCT05753501. IPD Sharing: NO. Countries: 9. Publications: 0.
An Observational Study on Infusion-related Adverse Events at Administration of MabThera (Rituximab) in Patients With Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT01072240. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.